Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting

Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting

Doxorubicin (DOX), a widely used drug in cancer chemotherapy, induces cell death via multiple intracellular interactions, generating reactive oxygen species and DNA-adducted configurations that induce apoptosis, topoisomerase II inhibition, and histone eviction. Despite its wide therapeutic efficacy...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Jihoon Lee, Min-Koo Choi, Im-Sook Song
Formato:	Artigo
Idioma:	English
Publicado em:	MDPI AG 2023-05-01
coleção:	Pharmaceuticals
Assuntos:	doxorubicin (DOX) formulation strategy drug resistance oral formulation
Acesso em linha:	https://www.mdpi.com/1424-8247/16/6/802

Registros relacionados

Molecular mechanisms associated with the chemoprotective role of protocatechuic acid and its potential benefits in the amelioration of doxorubicin-induced cardiotoxicity: A review
por: Edozie S. Okpara, et al.
Publicado em: (2022-01-01)

UHPLC-MS/MS Assay for Quantification of Legubicin, a Novel Doxorubicin-Based Legumain-Activated Prodrug, and Its Application to Pharmacokinetic and Tissue Distribution Studies
por: Liyuan Ma, et al.
Publicado em: (2024-02-01)

Salvage Chemotherapy in Recurrent Cervical Cancer With Biweekly Pegylated Liposomal Doxorubicin (Lipo-Dox)
por: Jen-Ruei Chen, et al.
Publicado em: (2008-09-01)

Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity
por: Rui Chen, et al.
Publicado em: (2023-08-01)

Quantitative analysis of doxorubicin hydrochloride and arterolane maleate by mid IR spectroscopy using transmission and reflectance modes
por: Ranju Bansal, et al.
Publicado em: (2021-04-01)

The influence of strategy formulation practices on the perceived financial performance of small and medium enterprises: The Zimbabwean experience
por: Mugove Mashingaidze, et al.
Publicado em: (2021-05-01)

Comparison of the Pharmacokinetics, Bioequivalence and Safety of Aqueous Progesterone Formulation Administered as either Intramuscular or Subcutaneous Injection versus Oil-based Progesterone Formulation Administered as Intramuscular Injection: A Randomised Study
por: Sonal Mehta, et al.
Publicado em: (2023-05-01)

DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways
por: Zaid H. Maayah, et al.
Publicado em: (2018-09-01)

Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)
por: Maimoona Chinwala
Publicado em: (2020-10-01)

An Alternative Source of Biopesticides and Improvement in Their Formulation—Recent Advances
por: Dragana Šunjka, et al.
Publicado em: (2022-11-01)

A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice
por: Satyanarayana R Pondugula, et al.
Publicado em: (2021-12-01)

Allicin and L-carnitine as Preventive Agents Against Doxorubicin-induced Cardiac Damage in Rats
por: Ahmed Soliman, et al.
Publicado em: (2024-08-01)

Effect of Alkaline Conditions on Forming an Effective G4.0 PAMAM Complex with Doxorubicin
por: Magdalena Szota, et al.
Publicado em: (2023-03-01)

What does Pesticide Formulation Have to Do with Anything?
por: Laurie Ann Hurner
Publicado em: (2016-08-01)

EFFECT OF THE C60 FULLERENE, DOXORUBICIN AND THEIR COMPLEX ON CANCER AND NORMAL CELLS OF BALB/c MICE
por: Prylutska S. V., et al.
Publicado em: (2014-02-01)

Research Progress on Oral Nano-formulation to Deliver Astaxanthin
por: Chen ZHONG, et al.
Publicado em: (2024-05-01)

Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
por: Soon-Seok Hong, et al.
Publicado em: (2019-10-01)

Hesperidin as a preventive resistance agent in MCF–7 breast cancer cells line resistance to doxorubicin
por: Rifki Febriansah, et al.
Publicado em: (2014-03-01)

Melatonin Restores Autophagic Flux by Activating the Sirt3/TFEB Signaling Pathway to Attenuate Doxorubicin-Induced Cardiomyopathy
por: Yanyan Ma, et al.
Publicado em: (2023-09-01)

Metacommunication in the judiciary field: formulations. A proposal for cataloging and an approach to facework in institutional contexts
por: Laura Mariottini
Publicado em: (2015-12-01)

Recent Advances in Propranolol Hydrochloride Formulations for the Treatment of Infantile Hemangiomas
por: Ren L, et al.
Publicado em: (2025-02-01)

90-Days Repeated Dose Oral Toxicity Study of Sharbat-e-Deenar (A Hepatoprotective Unani Herbal Formulation)
por: Gulam Mohammed Husain, et al.
Publicado em: (2021-03-01)

Exploitation of enrofloxacin-loaded docosanoic acid solid lipid nanoparticle suspension as oral and intramuscular sustained release formulations for pig
por: Yanfei Tao, et al.
Publicado em: (2019-01-01)

A Novel Berberine–Glycyrrhizic Acid Complex Formulation Enhanced the Prevention Effect to Doxorubicin-Induced Cardiotoxicity by Pharmacokinetic Modulation of Berberine in Rats
por: Shichang Zhang, et al.
Publicado em: (2022-07-01)

Development of Strategic Plan (Formulation, Implementation and Evaluation) of Physical Education in Lorestan Province by SWOT Approach
por: ahmadreza azizi, et al.
Publicado em: (2020-06-01)

DHP107, a novel oral paclitaxel formulation induces less peripheral neuropathic pain and pain-related molecular alteration than intravenous paclitaxel preparation in rat
por: Md. Mahbubur Rahman, et al.
Publicado em: (2019-08-01)

A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain
por: A Srivastava, et al.
Publicado em: (2012-01-01)

Advances in Yeast Probiotic Production and Formulation for Preventative Health
por: Ghaneshree Moonsamy, et al.
Publicado em: (2024-11-01)

Study of Oncolytic Virus Preservation and Formulation
por: Lina Pan, et al.
Publicado em: (2023-06-01)

Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen
por: Shin D, et al.
Publicado em: (2017-01-01)

Identification of co-regulated genes associated with doxorubicin resistance in the MCF-7/ADR cancer cell line
por: Ali Miri, et al.
Publicado em: (2023-06-01)

Study of Marketing Strategy Formulation at Ok Clean Laundry using SWOT Analysis
por: Awal Muhammad, et al.
Publicado em: (2022-01-01)

Influence of Differing Analgesic Formulations of Aspirin on Pharmacokinetic Parameters
por: Kunal Kanani, et al.
Publicado em: (2015-08-01)

Inflammatory Reprogramming Mediates Changes in Three-Dimensional Strain Capacity and Cardiac Function in Beagle Dogs with Doxorubicin-Related Cardiomyopathy
por: Yifan Chen, et al.
Publicado em: (2024-02-01)

Formulation Patents and Dermatology and Obviousness
por: Josephine Liu, et al.
Publicado em: (2011-11-01)

Effectiveness of polyherbal formulations for the treatment of type 2 Diabetes mellitus - A systematic review and meta-analysis
por: Renuka Suvarna, et al.
Publicado em: (2021-01-01)

Recent Advances in Nano-Formulations for Skin Wound Repair Applications
por: Lin Y, et al.
Publicado em: (2022-08-01)

Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
por: Hao Ji, et al.
Publicado em: (2021-09-01)

Doxorubicin/Nucleophosmin Binding Protein-Conjugated Nanoparticle Enhances Anti-leukemia Activity in Acute Lymphoblastic Leukemia Cells in vitro and in vivo
por: Donghui Gan, et al.
Publicado em: (2021-05-01)

Strategic Management Roadmap: Formulation, Implementation, and Evaluation to Develop Islamic Higher Education Institution
por: Junaidah Junaidah, et al.
Publicado em: (2020-12-01)